Aurinia Pharmaceuticals Inc.
US ˙ NasdaqGM ˙ CA05156V1022

SecurityAUPH / Aurinia Pharmaceuticals Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership274,574 shares
Latest Disclosed Value $ 4,069,187
Citadel Advisors Llc ownership in AUPH / Aurinia Pharmaceuticals Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 274,574 shares of Aurinia Pharmaceuticals Inc. (US:AUPH) valued at $4,069,187 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 779,495 shares of Aurinia Pharmaceuticals Inc.. This represents a change in shares of -64.78% during the quarter. The current value of the position is $4,349,252 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (AUPH) in the form of stock options. The firm currently holds call options representing 60,100 of underlying shares valued at $890,682 USD and put options representing 72,000 of underlying shares valued at $1,067,040 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

AUPH / Aurinia Pharmaceuticals Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 274,574 -504,921 -64.78 4,069 -67.27 0.0006
2026-02-17 2025-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 779,495 76,840 10.94 12,433 60.12 0.0019
2025-11-14 2025-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 702,655 585,018 497.31 7,764 679.52 0.0012
2025-08-14 2025-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 117,637 -3,340 -2.76 996 2.47 0.0002
2025-05-15 2025-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 120,977 -47,525 -28.20 973 -35.76 0.0002
2025-02-14 2024-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 168,502 -378,370 -69.19 1,513 -62.25 0.0003
2024-11-14 2024-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 546,872 -390,920 -41.69 4,009 -25.14 0.0008
2024-08-14 2024-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 937,792 669,389 249.40 5,355 298.36 0.0011
2024-05-15 2024-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 268,403 -310,262 -53.62 1,345 -74.16 0.0003
2024-02-14 2023-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 578,665 -59,239 -9.29 5,202 4.96 0.0010
2023-11-14 2023-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 637,904 275,906 76.22 4,957 41.44 0.0011
2023-08-14 2023-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 361,998 -2,085,275 -85.21 3,504 -86.94 0.0007
2023-05-15 2023-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 2,447,273 -1,329,989 -35.21 26,822 64.38 0.0059
2023-02-14 2022-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 3,777,262 1,027,146 37.35 16,318 -21.10 0.0038
2022-11-14 2022-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 2,750,116 1,880,872 216.38 20,681 136.73 0.0047
2022-08-15 2022-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 869,244 -279,902 -24.36 8,736 -38.60 0.0022
2022-05-16 2022-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 1,149,146 431,853 60.21 14,227 -13.27 0.0029
2022-02-14 2021-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 717,293 96,960 15.63 16,404 19.49 0.0034
2021-11-15 2021-09-30 13F AURINIA PHARMACEUTICALS Cmn 05156V102 620,333 -84,962 -12.05 13,728 50.18 0.0029
2021-08-16 2021-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 705,295 -727,898 -50.79 9,141 -50.88 0.0020
2021-05-21 2021-03-31 13F/A-1 AURINIA PHARMACEUTICALS COM 05156V102 1,433,193 -40,855 -2.77 18,610 -8.71 0.0046
2021-05-17 2021-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 1,433,193 -40,855 18,610 0.0046
2021-02-16 2020-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 1,474,048 -2,004,162 -57.62 20,386 -60.21 0.0053
2020-11-16 2020-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 3,478,210 2,578,478 286.58 51,234 250.41 0.0145
2020-08-14 2020-06-30 13F AURINIA PHARMACEUTICALS Cmn 05156V102 899,732 -358,654 -28.50 14,621 -19.92 0.0052
2020-05-15 2020-03-31 13F AURINIA PHARMACEUTICALS Cmn 05156V102 1,258,386 320,895 34.23 18,259 -3.86 0.0082
2020-02-14 2019-12-31 13F AURINIA PHARMACEUTICALS Cmn 05156V102 937,491 882,480 1,604.19 18,993 6,360.20 0.0082
2019-11-14 2019-09-30 13F AURINIA PHARMACEUTICALS Cmn 05156V102 55,011 -46,036 -45.56 294 -55.79 0.0001
2019-08-14 2019-06-30 13F AURINIA PHARMACEUTICALS Cmn 05156V102 101,047 -35,474 -25.98 665 -25.03 0.0003
2019-05-15 2019-03-31 13F AURINIA PHARMACEUTICALS Cmn 05156V102 136,521 20,363 17.53 887 11.99 0.0004
2019-02-14 2018-12-31 13F AURINIA PHARMACEUTICALS Cmn 05156V102 116,158 -20,029 -14.71 792 -12.39 0.0004
2018-11-13 2018-09-30 13F AURINIA PHARMACEUTICALS Cmn 05156V102 136,187 136,187 904 0.0004
2018-08-14 2018-06-30 13F/A-1 AURINIA PHARMACEUTICALS Cmn 05156V102 0 -50,922 -100.00 0 -100.00
2018-05-14 2018-03-31 13F/A-1 AURINIA PHARMACEUTICALS Cmn 05156V102 50,922 -76,367 -59.99 264 -54.25 0.0001
2018-05-11 2018-03-31 13F AURINIA PHARMACEUTICALS Cmn 05156V102 50,922 -76,367 264
2018-02-09 2017-12-31 13F AURINIA PHARMACEUTICALS Cmn 05156V102 127,289 115,389 969.66 577 669.33 0.0004
2017-11-09 2017-09-30 13F AURINIA PHARMACEUTICALS Cmn 05156V102 11,900 -61,370 -83.76 75 -83.30 0.0001
2017-08-11 2017-06-30 13F AURINIA PHARMACEUTICALS Cmn 05156V102 73,270 -95,933 -56.70 449 -63.85 0.0004
2017-05-12 2017-03-31 13F AURINIA PHARMACEUTICALS Cmn 05156V102 169,203 169,203 1,242 0.0011
2017-02-10 2016-12-31 13F ISOTECHNIKA PHARMA Cmn 05156V102 0 -15,236 -100.00 0 -100.00
2017-01-31 2016-09-30 13F/A-1 AURINIA PHARMACEUTICALS Cmn 05156V102 15,236 15,236 46 0.0000
2016-11-10 2016-09-30 13F ISOTECHNIKA PHARMA Cmn 05156V102 15,236 46 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F AURINIA PHARMACEUTICALS COM Call 60,100 -30.52 891 -35.46 n/a n/a n/a
2026-02-17 2025-12-31 13F AURINIA PHARMACEUTICALS COM Call 86,500 -37.32 1,380 -9.51 n/a n/a n/a
2025-11-14 2025-09-30 13F AURINIA PHARMACEUTICALS COM Call 138,000 2.83 1,525 34.15 n/a n/a n/a
2025-08-14 2025-06-30 13F AURINIA PHARMACEUTICALS COM Call 134,200 24.72 1,137 31.33 n/a n/a n/a
2025-05-15 2025-03-31 13F AURINIA PHARMACEUTICALS COM Call 107,600 -22.03 865 -30.19 n/a n/a n/a
2025-02-14 2024-12-31 13F AURINIA PHARMACEUTICALS COM Call 138,000 -2.47 1,239 19.48 n/a n/a n/a
2024-11-14 2024-09-30 13F AURINIA PHARMACEUTICALS COM Call 141,500 27.71 1,037 64.08 n/a n/a n/a
2024-08-14 2024-06-30 13F AURINIA PHARMACEUTICALS COM Call 110,800 -17.99 633 -6.51 n/a n/a n/a
2024-05-15 2024-03-31 13F AURINIA PHARMACEUTICALS COM Call 135,100 -77.99 677 -87.75 n/a n/a n/a
2024-02-14 2023-12-31 13F AURINIA PHARMACEUTICALS COM Call 613,900 19.44 5,519 38.19 n/a n/a n/a
2023-11-14 2023-09-30 13F AURINIA PHARMACEUTICALS COM Call 514,000 16.61 3,994 -6.40 n/a n/a n/a
2023-08-14 2023-06-30 13F AURINIA PHARMACEUTICALS COM Call 440,800 -43.29 4,267 -49.92 n/a n/a n/a
2023-05-15 2023-03-31 13F AURINIA PHARMACEUTICALS COM Call 777,300 5.24 8,519 167.05 n/a n/a n/a
2023-02-14 2022-12-31 13F AURINIA PHARMACEUTICALS COM Call 738,600 -7.64 3,191 -46.96 n/a n/a n/a
2022-11-14 2022-09-30 13F AURINIA PHARMACEUTICALS COM Call 799,700 -15.30 6,014 -36.62 n/a n/a n/a
2022-08-15 2022-06-30 13F AURINIA PHARMACEUTICALS COM Call 944,200 -22.42 9,489 -37.03 n/a n/a n/a
2022-05-16 2022-03-31 13F AURINIA PHARMACEUTICALS COM Call 1,217,100 -28.08 15,068 -61.07 n/a n/a n/a
2022-02-14 2021-12-31 13F AURINIA PHARMACEUTICALS COM Call 1,692,300 83.49 38,703 89.62 n/a n/a n/a
2021-11-15 2021-09-30 13F AURINIA PHARMACEUTICALS Cmn Call 922,300 115.14 20,411 267.37 n/a n/a n/a
2021-08-16 2021-06-30 13F AURINIA PHARMACEUTICALS COM Call 428,700 -8.30 5,556 -8.47 n/a n/a n/a
2021-05-21 2021-03-31 13F/A AURINIA PHARMACEUTICALS COM Call 467,500 12.22 6,070 5.35 n/a n/a n/a
2021-05-17 2021-03-31 13F AURINIA PHARMACEUTICALS COM Call 467,500 6,070 n/a n/a n/a
2021-02-16 2020-12-31 13F AURINIA PHARMACEUTICALS COM Call 416,600 79.88 5,762 68.92 n/a n/a n/a
2020-11-16 2020-09-30 13F AURINIA PHARMACEUTICALS COM Call 231,600 50.88 3,411 36.77 n/a n/a n/a
2020-08-14 2020-06-30 13F AURINIA PHARMACEUTICALS Cmn Call 153,500 -59.08 2,494 -54.18 n/a n/a n/a
2020-05-15 2020-03-31 13F AURINIA PHARMACEUTICALS Cmn Call 375,100 -38.23 5,443 -55.76 n/a n/a n/a
2020-02-14 2019-12-31 13F AURINIA PHARMACEUTICALS Cmn Call 607,300 585.44 12,304 2,501.27 n/a n/a n/a
2019-11-14 2019-09-30 13F AURINIA PHARMACEUTICALS Cmn Call 88,600 48.41 473 20.36 n/a n/a n/a
2019-08-14 2019-06-30 13F AURINIA PHARMACEUTICALS Cmn Call 59,700 5.11 393 6.50 n/a n/a n/a
2019-05-15 2019-03-31 13F AURINIA PHARMACEUTICALS Cmn Call 56,800 369 n/a n/a n/a
2018-11-13 2018-09-30 13F AURINIA PHARMACEUTICALS Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-08-14 2018-06-30 13F/A AURINIA PHARMACEUTICALS Cmn Call 25,700 -3.38 145 5.07 n/a n/a n/a
2018-08-10 2018-06-30 13F AURINIA PHARMACEUTICALS Cmn Call 25,700 145 n/a n/a n/a
2018-05-14 2018-03-31 13F/A AURINIA PHARMACEUTICALS Cmn Call 26,600 101.52 138 130.00 n/a n/a n/a
2018-05-11 2018-03-31 13F AURINIA PHARMACEUTICALS Cmn Call 26,600 138 n/a n/a n/a
2018-02-09 2017-12-31 13F AURINIA PHARMACEUTICALS Cmn Call 13,200 -85.51 60 -89.49 n/a n/a n/a
2017-11-09 2017-09-30 13F AURINIA PHARMACEUTICALS Cmn Call 91,100 -23.51 571 -21.78 n/a n/a n/a
2017-08-11 2017-06-30 13F AURINIA PHARMACEUTICALS Cmn Call 119,100 242.24 730 186.27 n/a n/a n/a
2017-05-12 2017-03-31 13F AURINIA PHARMACEUTICALS Cmn Call 34,800 255 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F AURINIA PHARMACEUTICALS COM Put 72,000 -33.82 1,067 -38.50 n/a n/a n/a
2026-02-17 2025-12-31 13F AURINIA PHARMACEUTICALS COM Put 108,800 -7.40 1,735 33.67 n/a n/a n/a
2025-11-14 2025-09-30 13F AURINIA PHARMACEUTICALS COM Put 117,500 69.55 1,298 121.50 n/a n/a n/a
2025-08-14 2025-06-30 13F AURINIA PHARMACEUTICALS COM Put 69,300 -45.56 587 -42.72 n/a n/a n/a
2025-05-15 2025-03-31 13F AURINIA PHARMACEUTICALS COM Put 127,300 -67.89 1,023 -71.26 n/a n/a n/a
2025-02-14 2024-12-31 13F AURINIA PHARMACEUTICALS COM Put 396,400 -4.41 3,560 17.11 n/a n/a n/a
2024-11-14 2024-09-30 13F AURINIA PHARMACEUTICALS COM Put 414,700 109.97 3,040 169.65 n/a n/a n/a
2024-08-14 2024-06-30 13F AURINIA PHARMACEUTICALS COM Put 197,500 -39.29 1,128 -30.82 n/a n/a n/a
2024-05-15 2024-03-31 13F AURINIA PHARMACEUTICALS COM Put 325,300 -40.84 1,630 -67.04 n/a n/a n/a
2024-02-14 2023-12-31 13F AURINIA PHARMACEUTICALS COM Put 549,900 9.67 4,944 26.91 n/a n/a n/a
2023-11-14 2023-09-30 13F AURINIA PHARMACEUTICALS COM Put 501,400 43.38 3,896 15.07 n/a n/a n/a
2023-08-14 2023-06-30 13F AURINIA PHARMACEUTICALS COM Put 349,700 -17.81 3,385 -27.41 n/a n/a n/a
2023-05-15 2023-03-31 13F AURINIA PHARMACEUTICALS COM Put 425,500 65.56 4,663 320.09 n/a n/a n/a
2023-02-14 2022-12-31 13F AURINIA PHARMACEUTICALS COM Put 257,000 -6.72 1,110 -46.43 n/a n/a n/a
2022-11-14 2022-09-30 13F AURINIA PHARMACEUTICALS COM Put 275,500 -46.35 2,072 -59.85 n/a n/a n/a
2022-08-15 2022-06-30 13F AURINIA PHARMACEUTICALS COM Put 513,500 -61.22 5,161 -68.52 n/a n/a n/a
2022-05-16 2022-03-31 13F AURINIA PHARMACEUTICALS COM Put 1,324,100 -20.54 16,392 -56.99 n/a n/a n/a
2022-02-14 2021-12-31 13F AURINIA PHARMACEUTICALS COM Put 1,666,400 43.38 38,111 48.18 n/a n/a n/a
2021-11-15 2021-09-30 13F AURINIA PHARMACEUTICALS Cmn Put 1,162,200 53.06 25,719 161.35 n/a n/a n/a
2021-08-16 2021-06-30 13F AURINIA PHARMACEUTICALS COM Put 759,300 -10.70 9,841 -10.87 n/a n/a n/a
2021-05-21 2021-03-31 13F/A AURINIA PHARMACEUTICALS COM Put 850,300 70.09 11,041 59.69 n/a n/a n/a
2021-05-17 2021-03-31 13F AURINIA PHARMACEUTICALS COM Put 850,300 11,041 n/a n/a n/a
2021-02-16 2020-12-31 13F AURINIA PHARMACEUTICALS COM Put 499,900 232.16 6,914 211.86 n/a n/a n/a
2020-11-16 2020-09-30 13F AURINIA PHARMACEUTICALS COM Put 150,500 11.98 2,217 1.51 n/a n/a n/a
2020-08-14 2020-06-30 13F AURINIA PHARMACEUTICALS Cmn Put 134,400 -24.32 2,184 -15.25 n/a n/a n/a
2020-05-15 2020-03-31 13F AURINIA PHARMACEUTICALS Cmn Put 177,600 -45.08 2,577 -60.67 n/a n/a n/a
2020-02-14 2019-12-31 13F AURINIA PHARMACEUTICALS Cmn Put 323,400 -26.35 6,552 179.40 n/a n/a n/a
2019-11-14 2019-09-30 13F AURINIA PHARMACEUTICALS Cmn Put 439,100 1,267.91 2,345 1,011.37 n/a n/a n/a
2019-08-14 2019-06-30 13F AURINIA PHARMACEUTICALS Cmn Put 32,100 56.59 211 58.65 n/a n/a n/a
2019-05-15 2019-03-31 13F AURINIA PHARMACEUTICALS Cmn Put 20,500 -49.13 133 -51.64 n/a n/a n/a
2019-02-14 2018-12-31 13F AURINIA PHARMACEUTICALS Cmn Put 40,300 -18.59 275 -16.41 n/a n/a n/a
2018-11-13 2018-09-30 13F AURINIA PHARMACEUTICALS Cmn Put 49,500 25.00 329 47.53 n/a n/a n/a
2018-08-14 2018-06-30 13F/A AURINIA PHARMACEUTICALS Cmn Put 39,600 -10.00 223 -2.19 n/a n/a n/a
2018-08-10 2018-06-30 13F AURINIA PHARMACEUTICALS Cmn Put 39,600 223 n/a n/a n/a
2018-05-14 2018-03-31 13F/A AURINIA PHARMACEUTICALS Cmn Put 44,000 -61.94 228 -56.49 n/a n/a n/a
2018-05-11 2018-03-31 13F AURINIA PHARMACEUTICALS Cmn Put 44,000 228 n/a n/a n/a
2018-02-09 2017-12-31 13F AURINIA PHARMACEUTICALS Cmn Put 115,600 32.72 524 -4.03 n/a n/a n/a
2017-11-09 2017-09-30 13F AURINIA PHARMACEUTICALS Cmn Put 87,100 7.13 546 9.64 n/a n/a n/a
2017-08-11 2017-06-30 13F AURINIA PHARMACEUTICALS Cmn Put 81,300 -57.83 498 -64.81 n/a n/a n/a
2017-05-12 2017-03-31 13F AURINIA PHARMACEUTICALS Cmn Put 192,800 1,415 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.